CoChat

The human leukocyte antigen-presented ligandome of B lymphocytes

Hassan, Chopie, Kester, Michel G.D., de Ru, Arnoud H., Hombrink, Pleun, Drijfhout, Jan Wouter, Nijveen, Harm, Leunissen, Jack A.M., Heemskerk, Mirjam H.M., Falkenburg, J.H. Frederik, van Veelen, Peter A. · 2013 · Molecular & Cellular Proteomics
Cited by 98

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1074/mcp.m112.024810

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 51

  1. Kenter, 2009, Vaccination against HPV-16 oncoproteins for vulvar intraepithelial neoplasia, N. Engl. J. Med, 361, 1838, 10.1056/NEJMoa0810097 · DOI · Paper page
  2. Falkenburg, 2002, Minor histocompatibility antigens as targets of graft-versus-leukemia reactions, Curr. Opin. Hematol, 9, 497, 10.1097/00062752-200211000-00005 · DOI
  3. Yewdell, 2003, Making sense of mass destruction: quantitating MHC class I antigen presentation, Nat. Rev. Immunol, 3, 952, 10.1038/nri1250 · DOI · Paper page
  4. Kessler, 2011, Antigen processing by nardilysin and thimet oligopeptidase generates cytotoxic T cell epitopes, Nat. Immunol, 12, 45, 10.1038/ni.1974 · DOI
  5. Vigneron, 2004, An antigenic peptide produced by peptide splicing in the proteasome, Science, 304, 587, 10.1126/science.1095522 · DOI · Paper page
  6. van Bergen, 2007, Multiple myeloma-reactive T cells recognize an activation-induced minor histocompatibility antigen encoded by the ATP-dependent interferon-responsive (ADIR) gene, Blood, 109, 4089, 10.1182/blood-2006-08-043935 · DOI
  7. Scull, 2012, Secreted HLA recapitulates the immunopeptidome and allows in-depth coverage of HLA A*02:01 ligands, Mol. Immunol, 51, 136, 10.1016/j.molimm.2012.02.117 · DOI · Paper page
  8. Granados, 2012, MHC I-associated peptides preferentially derive from transcripts bearing miRNA response elements, Blood, 119, e181, 10.1182/blood-2012-02-412593 · DOI
  9. Bade-Doeding, 2011, Mismatches outside exons 2 and 3 do not alter the peptide motif of the allele group B*44:02P, Hum. Immunol, 72, 1039, 10.1016/j.humimm.2011.08.004 · doi:10.1016/j.humimm.2011.08.004
  10. Mester, 2011, Insights into MHC class I antigen processing gained from large-scale analysis of class I ligands, Cell. Mol. Life Sci, 68, 1521, 10.1007/s00018-011-0659-9 · DOI
  11. den Haan, 1998, The minor histocompatibility antigen HA-1: a diallelic gene with a single amino acid polymorphism, Science, 279, 1054, 10.1126/science.279.5353.1054 · DOI · Paper page
  12. den Haan, 1995, Identification of a graft versus host disease-associated human minor histocompatibility antigen, Science, 268, 1476, 10.1126/science.7539551 · doi:10.1126/science.7539551
  13. Warren, 2006, An antigen produced by splicing of noncontiguous peptides in the reverse order, Science, 313, 1444, 10.1126/science.1130660 · DOI · Paper page
  14. Bansal, 2010, CD8 T cell response and evolutionary pressure to HIV-1 cryptic epitopes derived from antisense transcription, J. Exp. Med, 207, 51, 10.1084/jem.20092060 · DOI
  15. Berger, 2010, Viral adaptation to immune selection pressure by HLA class I-restricted CTL responses targeting epitopes in HIV frameshift sequences, J. Exp. Med, 207, 61, 10.1084/jem.20091808 · DOI
  16. Hombrink, 2011, High-throughput identification of potential minor histocompatibility antigens by MHC tetramer-based screening: feasibility and limitations, PLoS One, 6, e22523, 10.1371/journal.pone.0022523 · DOI
  17. Hadrup, 2010, MHC-based detection of antigen-specific CD8+ T cell responses, Cancer Immunol. Immunother, 59, 1425, 10.1007/s00262-010-0824-2 · DOI
  18. Kersey, 2004, The International Protein Index: an integrated database for proteomics experiments, Proteomics, 4, 1985, 10.1002/pmic.200300721 · DOI · Paper page
  19. Nijveen, 2011, HSPVdb—the Human Short Peptide Variation Database for improved mass spectrometry-based detection of polymorphic HLA-ligands, Immunogenetics, 63, 143, 10.1007/s00251-010-0497-1 · doi:10.1007/s00251-010-0497-1
  20. Meadows, 1997, The HLA-A*0201-restricted H-Y antigen contains a posttranslationally modified cysteine that significantly affects T cell recognition, Immunity, 6, 273, 10.1016/S1074-7613(00)80330-1 · DOI · Paper page
  21. Meyer, 2009, Identification of natural MHC class II presented phosphopeptides and tumor-derived MHC class I phospholigands, J. Proteome Res, 8, 3666, 10.1021/pr800937k · DOI · Paper page
  22. Admon, 2011, The Human Immunopeptidome Project, a suggestion for yet another postgenome next big thing, Mol. Cell. Proteomics, 10.1074/mcp.O111.011833 · DOI
  23. Kondo, 2004, Identification of novel CTL epitopes of CMV-pp65 presented by a variety of HLA alleles, Blood, 103, 630, 10.1182/blood-2003-03-0824 · DOI · Paper page
  24. Heemskerk, 2001, Dual HLA class I and class II restricted recognition of alloreactive T lymphocytes mediated by a single T cell receptor complex, Proc. Natl. Acad. Sci. U.S.A, 98, 6806, 10.1073/pnas.111162298 · DOI
  25. Meiring, 2002, Nanoscale LC-MS(n): technical design and applications to peptide and protein analysis, J. Sep. Sci, 25, 557, 10.1002/1615-9314(20020601)25:9<557::AID-JSSC557>3.0.CO;2-F · DOI · Paper page
  26. Colaert, 2009, Improved visualization of protein consensus sequences by iceLogo, Nat. Methods, 6, 786, 10.1038/nmeth1109-786 · DOI · Paper page
  27. Hornbeck, 2012, PhosphoSitePlus: a comprehensive resource for investigating the structure and function of experimentally determined post-translational modifications in man and mouse, Nucleic Acids Res, 40, D261, 10.1093/nar/gkr1122 · DOI · Paper page
  28. Dinkel, 2011, Phospho.ELM: a database of phosphorylation sites—update 2011, Nucleic Acids Res, 39, D261, 10.1093/nar/gkq1104 · DOI · Paper page
  29. Blom, 1999, Sequence and structure-based prediction of eukaryotic protein phosphorylation sites, J. Mol. Biol, 294, 1351, 10.1006/jmbi.1999.3310 · DOI · Paper page
  30. Pruitt, 2005, NCBI Reference Sequence (RefSeq): a curated non-redundant sequence database of genomes, transcripts and proteins, Nucleic Acids Res, 33, D501, 10.1093/nar/gki025 · DOI · Paper page
  31. Hubner, 2008, Peptide separation with immobilized pI strips is an attractive alternative to in-gel protein digestion for proteome analysis, Proteomics, 8, 4862, 10.1002/pmic.200800351 · DOI · Paper page
  32. Rammensee, 1999, SYFPEITHI: database for MHC ligands and peptide motifs, Immunogenetics, 50, 213, 10.1007/s002510050595 · DOI · Paper page
  33. Bleakley, 2004, Molecules and mechanisms of the graft-versus-leukaemia effect, Nat. Rev. Cancer, 4, 371, 10.1038/nrc1365 · DOI · Paper page
  34. Goulmy, 1996, Human minor histocompatibility antigens, Curr. Opin. Immunol, 8, 75, 10.1016/S0952-7915(96)80108-7 · DOI · Paper page
  35. Mutis, 2002, Hematopoietic system-specific antigens as targets for cellular immunotherapy of hematological malignancies, Semin. Hematol, 39, 23, 10.1053/shem.2002.29248 · doi:10.1053/shem.2002.29248
  36. Laurin, 2010, Immunomonitoring of graft-versus-host minor histocompatibility antigen correlates with graft-versus-host disease and absence of relapse after graft, Transfusion, 50, 418, 10.1111/j.1537-2995.2009.02440.x · DOI
  37. Zarling, 2006, Identification of class I MHC-associated phosphopeptides as targets for cancer immunotherapy, Proc. Natl. Acad. Sci. U.S.A, 103, 14889, 10.1073/pnas.0604045103 · DOI · Paper page
  38. Dudek, 2012, Constitutive and inflammatory immunopeptidome of pancreatic beta-cells, Diabetes, 61, 3018, 10.2337/db11-1333 · DOI
  39. Chornoguz, 2012, Major histocompatibility complex class II+ invariant chain negative breast cancer cells present unique peptides that activate tumor-specific T cells from breast cancer patients, Mol. Cell. Proteomics, 11, 1457, 10.1074/mcp.M112.019232 · DOI
  40. Hunt, 1992, Characterization of peptides bound to the class I MHC molecule HLA-A2.1 by mass spectrometry, Science, 255, 1261, 10.1126/science.1546328 · DOI · Paper page
  41. Maier, 1994, Peptide motifs of HLA-A3, -A24, and -B7 molecules as determined by pool sequencing, Immunogenetics, 40, 306, 10.1007/BF00189978 · DOI
  42. Huczko, 1993, Characteristics of endogenous peptides eluted from the class I MHC molecule HLA-B7 determined by mass spectrometry and computer modeling, J. Immunol, 151, 2572, 10.4049/jimmunol.151.5.2572 · DOI · Paper page
  43. Macdonald, 2002, Identification of a dominant self-ligand bound to three HLA B44 alleles and the preliminary crystallographic analysis of recombinant forms of each complex, FEBS Lett, 527, 27, 10.1016/S0014-5793(02)03149-6 · DOI
  44. Liu, 2012, The energetic basis underpinning T-cell receptor recognition of a super-bulged peptide bound to a major histocompatibility complex class I molecule, J. Biol. Chem, 287, 12267, 10.1074/jbc.M112.344689 · DOI
  45. Engelhard, 1978, Induction of secondary cytotoxic T lymphocytes by purified HLA-A and HLA-B antigens reconstituted into phospholipid vesicles, Proc. Natl. Acad. Sci. U.S.A, 75, 5688, 10.1073/pnas.75.11.5688 · DOI
  46. Meiring, 2005, Mass tag-assisted identification of naturally processed HLA class II-presented meningococcal peptides recognized by CD4+ T lymphocytes, J. Immunol, 174, 5636, 10.4049/jimmunol.174.9.5636 · doi:10.4049/jimmunol.174.9.5636
  47. van Haren, 2011, HLA-DR-presented peptide repertoires derived from human monocyte-derived dendritic cells pulsed with blood coagulation factor VIII, Mol. Cell. Proteomics, 10, 10.1074/mcp.M110.002246 · DOI · Paper page
  48. Tan, 2011, Direct quantitation of MHC-bound peptide epitopes by selected reaction monitoring, Proteomics, 11, 2336, 10.1002/pmic.201000531 · DOI · Paper page
  49. Weinzierl, 2007, Distorted relation between mRNA copy number and corresponding major histocompatibility complex ligand density on the cell surface, Mol. Cell. Proteomics, 6, 102, 10.1074/mcp.M600310-MCP200 · DOI · Paper page
  50. Yewdell, 2011, DRiPs solidify: progress in understanding endogenous MHC class I antigen processing, Trends Immunol, 32, 548, 10.1016/j.it.2011.08.001 · DOI · Paper page
  51. Pinkse, 2008, Highly robust, automated, and sensitive online TiO2-based phosphoproteomics applied to study endogenous phosphorylation in Drosophila melanogaster, J. Proteome Res, 7, 687, 10.1021/pr700605z · DOI · Paper page

Cited by

See all 98

Metadata

Authors
Hassan, C., Kester, M. G. D., de Ru, A. H., Hombrink, P., Drijfhout, J. W., Nijveen, H., Leunissen, J. A. M., Heemskerk, M. H. M., Falkenburg, J. H. F., & van Veelen, P. A.
Venue
Molecular & Cellular Proteomics
Publisher
Elsevier BV
Published
2013-07
Volume
12
Issue
7
Pages
1829-1843
ISSN
1535-9476
Cited by
98
References
7
Language
en
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.